While some medicines require precise timing, many just need consistency. Taking them at roughly the same time every day helps ...

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular ...

In 502 patients with end-stage kidney disease (ESKD) receiving hemodialysis via AVG, time to a graft thrombosis event was not significantly different for those on 6 mg of MK-2060 (HR 0.83, 95% CI ...

Individual heterogeneity in responsiveness to antiplatelet agents may be due to either inherited or acquired factors. These potential variables include genetic polymorphisms in platelet proteins ...

The directive to use more antiplatelet therapy was one of the biggest changes ... area for the hospitalist to know is that if the patient requires the addition of an anticoagulant, then the aspirin ...

Data Sources: An English-language literature search was conducted using MEDLINE (1966–March 2008) and the search terms aspirin, clopidogrel, ticlopidine, thienopyridine, warfarin, antiplatelet ...

Risk for stroke recurrence is not decreased with the addition of oral anticoagulation to standard antiplatelet therapy following acute ischemic stroke.

Included studies: Continuation of antiplatelet drugs during the perioperative period (aspirin or dual anticoagulant therapy was not stopped before surgery) compared with the group that stopped using ...

The advent of direct oral anticoagulants (DOACs) revolutionised the therapy of AF; less is known, however, about the safety and efficacy of therapy with DOACs in combination with antiplatelet agents ...

Antiplatelets are a group of different medicines that can prevent potentially fatal clot formation in the blood vessels ('thrombotic events'). For hospitalised patients with COVID-19, they probably ...

Coronary artery bypass grafting (CABG) has been associated with reduced mortality, myocardial infarction, and repeat revascularization compared with percutaneous coronary intervention (PCI) for ...